IMPG1 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:3617, GP147, HGNC:6055, IMPG1, IPM150, MIM:602870, NM_001282368, NM_001563, NP_001269297, NP_001554, SPACR, VMD4, interphotoreceptor matrix proteoglycan 1

Omim:OMIM:602870

Id:ENSG00000112706

Hgnc:HGNC:6055

Entrez:3617

Ensembl:ENSG00000112706

Description:interphotoreceptor matrix proteoglycan 1

This gene encodes a protein that is a major component of the retinal interphotoreceptor matrix. The encoded protein is a proteoglycan that is thought to play a role in maintaining viability of photoreceptor cells and in adhesion of the neural retina to the retinal pigment epithelium. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View IMPG1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with IMPG1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using IMPG1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for IMPG1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with IMPG1.

Results found

Linked to

	Label	Description
	GSE226249 5 V 4 PIRFENIDONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE200099 3 V 1 HONOKIOL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE205674 TEPP-46 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE178975 GSE178978 EGFR inhibition 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 13 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE129241 3 V 6 VALPROIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE226249 5 V 4 PIRFENIDONE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE200099 3 V 1 HONOKIOL HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE205674 TEPP-46 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE100148 EZH2 inhibition 0 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE178975 GSE178978 EGFR inhibition 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 13 v 14 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE129241 3 V 6 VALPROIC ACID HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE261563 CX-5461 5 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.